Noninvasive, Blood-Based Biomarkers as Screening Tools for Hepatic Fibrosis in People With Type 2 DiabetesAngeliki Meritsi, Anastasia Thanopoulou, Dimitra Latsou et al.|Clinical Diabetes|2022Cited by 6
<i>PNPLA3 rs 738409</i> and Other Nongenetic Factors Associated with Hepatic Steatosis Estimated by Magnetic Resonance Imaging Proton Density Fat Fraction in Adult Greek Subjects with Type 2 Diabetes MellitusAngeliki Meritsi, Anastasia Thanopoulou, Panagiotis Koussis et al.|Metabolic Syndrome and Related Disorders|2021Cited by 2
Blood based biomarkers as non-invasive screening tools for hepatic fibrosis in subjects with Type 2 Diabetes MellitusAngeliki Meritsi, Anastasia Thanopoulou, Dimitra Latsou et al.|Metabolism|2022Cited by 1
Factors associated with hepatic steatosis in adult Greek subjects with type 2 diabetes mellitusAngeliki Meritsi, Anastasia Thanopoulou, Emanuel K. Manesis et al.|Metabolism|2022Cited by 1
Association of PNPLA3 and TM6SF2 Polymorphisms with NAFLD in Greek People with Type 2 Diabetes MellitusAngeliki Meritsi, Anastasia Thanopoulou, Stamatia Rapti et al.|Metabolism|2023Cited by 0